FDA Approved: BUSULFAN — Original Application (Armas Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic Busulfan from Armas Pharmaceuticals Inc. under ANDA210931, enabling a generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Aplastic Anemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

ORIG AP for BUSULFAN (BUSULFAN)